Paclitaxel adds benefit to ifosfamide in uterine cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1582-1583, 2007-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel benefit in breast cancer linked to HER2 expression

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Tocilizumab adds to benefit with methotrexate in refractory RA

By  

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Taxane-based adjuvant adds to survival in breast cancer

By  

Inpharma, Vol. 1, Iss. 1623, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Paclitaxel in cancer therapy

By Markman Maurie   Mekhail Tarek M  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 755-766

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel poliglumex for ovarian cancer

By Galic Vijaya L   Wright Jason D   Lewin Sharyn N   Herzog Thomas J  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 813-821

Informa Healthcare

Access to resources Recommend Favorite